Editorial: Immune checkpoint inhibitors in cancer: balancing the benefits with the side effects?

Gomes-Lima, Cristiane J; Zhou, Wen; Quandt, Zoe

Gomes-Lima, Cristiane J; Zhou, Wen; Quandt, Zoe.

Affiliation

Gomes-Lima CJ; Department of Medicine, Oncoclinicas Group, Brasilia, DF, Brazil.
Zhou W; Department of Comprehensive Care, Case Western Reserve University School of Dental Medicine, Cleveland, OH, United States.
Quandt Z; Division of Endocrinology and Metabolism, Department of Medicine, University of California, San Francisco, San Francisco, CA, United States.

Front Endocrinol (Lausanne) ; 14: 1268402, 2023.

Article in En | MEDLINE | ID: mdl-37766679

Subject(s)

Antineoplastic Agents, Immunological; Neoplasms; Humans; Immune Checkpoint Inhibitors/adverse effects; Neoplasms/chemically induced; Antineoplastic Agents, Immunological/adverse effects

Key words

adverse events; cancer; endocrine glands; immune checkpoint inhibitors (ICI); immunotherapy

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Antineoplastic Agents, Immunological / Neoplasms Limits: Humans Language: En Journal: Front Endocrinol (Lausanne) Year: 2023 Document type: Article Affiliation country: Brazil

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google